Shandong Huaxi Pharmaceutical Co.,Ltd. is a special drug production enterprise which is invested and managed by Beijing Huaxi Unit Technology Group. The company covers an area of 118 mu and is planed and designed by Shandong Pharmaceutical Design Institute. Total investment is 90 million yuan. Huanxi Unit Technology Group is the pharmaceutical organization which dedicates to technology innovation and contract service. At present, we own, more than 1,500 square meters of standard labs and have established branches and cooperation labs in America, Britain, India and Hong Kong. Huaxi Co.,Ltd owns energetic specialization team and consultation group which is consisted of tens of experienced experts with pharmaceutical development, production, clinic, business and cost market. They have worked on pharmaceutical development for years, and have good pharmaceutical special background and pharmaceutical research and development. Beijing headquarter has dedicated to research and development of all kinds of new drugs, and carries on many pharmaceutical development service business depending on strong technical power and good cooperation background. Products include more than ten treatment fields containing anti-infectious agent, antineoplastic drug, antidiabetic and others. Strong technical support and rich power resources make us quickly own strong agglomeration and battle effectiveness. We soon become the leading enterprise in pharmaceutical development field of China. We wish to create excellent international pharmaceutical development, processing and service group in future. Huaxi Pharmaceutical is processing in internationalization and industrialization road, and always dedicates to specialization services from development, production and clinic to market and accelerates industrial technical process. At last, we respond the society.
